EN
EN
FR
ES
PT
AR
RU
DE
IT
NL
TH
KO
VI
ID
Home
Kexing Biopharm
About Us
Kexing Brand
Brand Connotation
Corporate Culture
Honors
History
Global Business
Global Commercial Cooperation Strategy
Commercialization platform
Commercialization capability
Commercial Cooperation Graph
R&D and Innovation
Global R&D Center
R&D field
Animal Vaccine
Synthetic Biology
SANCTINUS
Our Medicines
Infliximab for Injection
Bevacizumab Injection
Adalimumab Solution for Injection
Paclitaxel for Injection(Albumin-Bound)
Human Erythropoietin Injection
Human Granulocyte Colony-stimulating Factor Injection
Combined Clostridium and Bifidobacterium,Live
Human Interferon α1b for Injection
Kehuang Capsule
Entecavir Tablets
α-ketoglutarate(AKG)
5-aminnolevulinic acid (5-ALA)
Recombinant Collagen Repair Mask
Recombinant Collagen Anti-Wrinkle Single Use Essence
Quality Control
Quality system
Compliant production
Pharmacovigilance
ESG
Global health
Support Community
Environmental protection
News
News and information
Video Center
Contact
Contact Us
Join Us
NEWS AND INFORMATION
Home
/
News
/
News and information
/
Kexing Biopharm...
Kexing Biopharm's Product Catalog (Core Product)
Article source:Kexing Biopharm
Jun 17,2025
View: 1865
LABEL:
< Kexing Biopharm's Product Introduction
Kexing Biopharm: A leader in China Recombinant Protein Therapeutics Industry >
BACK TO LIST
Related News
Jan 01,2025
Is China Becoming a Global Leader in Biological Products Exports?
READ MORE >>
Jan 03,2025
Synthetic Biology: Driving the Next Generation of Biomanufacturing
READ MORE >>
Oct 17,2023
The Benefits and Risks of Human Erythropoietin Injection: What You Need to Know
READ MORE >>
Jul 31,2024
Kexing Biopharm's Albumin-bound Paclitaxel Granted EU Market Approval
READ MORE >>
Jul 13,2023
China's first infliximab biosimilar drug ready for export, Kexing Biopharm initiated drug registration in 17 countries
READ MORE >>
Jun 17,2025
Kexing Biopharm's Product Introduction
READ MORE >>
Home
Kexing Biopharm
About Us
Kexing Brand
Brand Connotation
Corporate Culture
Honors
History
Global Business
Global Commercial Cooperation Strategy
Commercialization platform
Commercialization capability
Commercial Cooperation Graph
R&D and Innovation
Global R&D Center
R&D field
Animal Vaccine
Synthetic Biology
SANCTINUS
Our Medicines
Infliximab for Injection
Bevacizumab Injection
Adalimumab Solution for Injection
Paclitaxel for Injection(Albumin-Bound)
Human Erythropoietin Injection
Human Granulocyte Colony-stimulating Factor Injection
Combined Clostridium and Bifidobacterium,Live
Human Interferon α1b for Injection
Kehuang Capsule
Entecavir Tablets
α-ketoglutarate(AKG)
5-aminnolevulinic acid (5-ALA)
Recombinant Collagen Repair Mask
Recombinant Collagen Anti-Wrinkle Single Use Essence
Quality Control
Quality system
Compliant production
Pharmacovigilance
ESG
Global health
Support Community
Environmental protection
News
News and information
Video Center
Contact
Contact Us
Join Us